Effects of exhaustive stretch-shortening cycle exercise on muscle blood flow during exercise. 2006

M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
Turku PET Centre, University of Turku, Turku, Finland. marko.laaksonen@miun.se

OBJECTIVE The influence of exhaustive stretch-shortening cycle exercise (SSC) on skeletal muscle blood flow (BF) during exercise is currently unknown. METHODS Quadriceps femoris (QF) BF was measured in eight healthy men using positron emission tomography before and 3 days after exhaustive SSC exercise. The SSC protocol consisted of maximal and submaximal drop jumps with one leg. Needle biopsies of the vastus lateralis muscles were taken immediately and 2 days after SSC for muscle endothelial nitric oxide synthase (eNOS) and interleukin-1-beta (IL-1beta) mRNA level determinations. RESULTS All subjects reported subjective muscle soreness after SSC (P < 0.001), which was well in line with a decrease in maximal isometric contraction force (MVC) and increase in serum creatine kinase activity (CK) (P = 0.018). After SSC muscle BF was 25% higher in entire QF (P = 0.043) and in its deep and superficial muscle regions, whereas oxygen uptake remained unchanged (P = 0.893). Muscle biopsies revealed increased IL-1beta (30 min: 152 +/- 75%, P = 0.012 and 2 days: 108 +/- 203%, P = 0.036) but decreased or unchanged eNOS (30 min; -21 +/- 57%, P = 0.050 and 2 days: +101 +/- 204%, P = 0.779) mRNA levels after SSC. CONCLUSIONS It was concluded that fatiguing SSC exercise induces increased muscle BF during exercise, which is likely to be associated with pro-inflammatory processes in the exercised muscle.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007537 Isometric Contraction Muscular contractions characterized by increase in tension without change in length. Contraction, Isometric,Contractions, Isometric,Isometric Contractions
D008297 Male Males
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
February 2007, Scandinavian journal of medicine & science in sports,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
October 2007, Scandinavian journal of medicine & science in sports,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
January 2019, Frontiers in physiology,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
March 2007, Medicine and science in sports and exercise,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
September 2011, European journal of applied physiology,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
March 1998, Medicine and science in sports and exercise,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
May 2004, European journal of applied physiology,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
August 2012, European journal of applied physiology,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
January 2014, Journal of sports science & medicine,
M S Laaksonen, and R Kivelä, and H Kyröläinen, and S Sipilä, and H Selänne, and R Lautamäki, and P Nuutila, and J Knuuti, and K K Kalliokoski, and P V Komi
March 2006, Research quarterly for exercise and sport,
Copied contents to your clipboard!